Discover
ANIP
ANI Pharmaceuticals, Inc.
83.05
2 x 59.52
2 x 106.26
bid
ask
+
0.27
0.33%
2 @ 04:00 PM
83.05 +0.00 (0.00%)
| Ytd | 5.21% | |
| 1y | 30.66% |
82.38
day range
84.82
62.61
52 week range
99.50
| Open | 83.45 | Prev Close | 82.78 | Low | 82.38 | High | 84.82 | Mkt Cap | 1.89B |
| Vol | 249.44K | Avg Vol | 356.52K | EPS | 3.91 | P/E | 21.24 | Forward P/E | 7.77 |
| Beta | 0.44 | Short Ratio | 10.11 | Inst. Own | 110.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 80.78 | 200-d Avg | 82.51 | 1yr Est | 112.71 |
| Income Statement | |||
| Total Revenue | 237.46M | ||
| Revenues (USD) | 237.46M | ||
| Cost of Revenue | 93.58M | ||
| Gross Profit | 143.88M | ||
| Operating Expenses | 105.17M | ||
| Research and Development Expense | 10.60M | ||
| Selling, General and Administrative Expense | 73.66M | ||
| Operating Income | 38.71M | ||
| Interest Expense | 3.77M | ||
| Income Tax Expense | 10.73M | ||
| Net Income | 29.49M | ||
| Net Income Common Stock | 29.49M | ||
| Net Income Common Stock (USD) | 29.49M | ||
| Consolidated Income | 29.49M | ||
| Earnings per Basic Share | 1.31 | ||
| Earnings per Basic Share (USD) | 1.31 | ||
| Earnings per Diluted Share | 1.28 | ||
| Earning Before Interest & Taxes (EBIT) | 43.99M | ||
| Earning Before Interest & Taxes (USD) | 43.99M | ||
| Weighted Average Shares | 21.54M | ||
| Weighted Average Shares Diluted | 21.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 311.21M | ||
| Cash and Equivalents (USD) | 311.21M | ||
| Investments | 14.89M | ||
| Investments Current | 14.89M | ||
| Trade and Non-Trade Receivables | 255.43M | ||
| Current Assets | 747.08M | ||
| Property, Plant & Equipment Net | 67.11M | ||
| Total Assets | 1.42B | ||
| Debt Current | 19.30M | ||
| Total Debt | 613.76M | ||
| Current Liabilities | 239.51M | ||
| Debt Non-Current | 594.46M | ||
| Total Liabilities | 859.67M | ||
| Accumulated Retained Earnings (Deficit) | 6.39M | ||
| Accumulated Other Comprehensive Income | 479.00K | ||
| Shareholders Equity | 562.30M | ||
| Shareholders Equity (USD) | 562.30M | ||
| Assets Non-Current | 674.89M | ||
| Total Debt (USD) | 613.76M | ||
| Goodwill and Intangible Assets | 529.64M | ||
| Inventory | 143.47M | ||
| Liabilities Non-Current | 620.16M | ||
| Trade and Non-Trade Payables | 69.69M | ||
| Tax Assets | 66.56M | ||
| Tax Liabilities | 5.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 21.37M | ||
| Net Cash Flow from Financing | -21.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.59M | ||
| Capital Expenditure | -6.07M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.25M | ||
| Issuance (Purchase) of Equity Shares | -17.55M | ||
| Issuance (Repayment) of Debt Securities | -4.06M | ||
| Net Cash Flow from Investing | -11.32M | ||
| Net Cash Flow from Operations | 58.38M | ||
| Effect of Exchange Rate Changes on Cash | 156.00K | ||
| Share Based Compensation | 10.19M | ||